Cognition Therapeutics, Inc. Common Stock (CGTX) is a publicly traded Healthcare sector company. As of May 21, 2026, CGTX trades at $1.25 with a market cap of $97.55M and a P/E ratio of -3.98. CGTX moved +15.32% today. Year to date, CGTX is -7.86%; over the trailing twelve months it is +281.43%. Its 52-week range spans $0.22 to $3.83. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces CGTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes CGTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $1.25 |
| Market Cap | $97.55M |
| P/E Ratio | -3.98 |
| EPS | $-0.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.83 |
| 52-Week Low | $0.22 |
| Volume | 34.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-23.49M |
| Gross Margin | 0.00% |
2 analysts cover CGTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.